Oak Associates LTD Trimmed By $399,900 Its Quest Diagnostics (DGX) Holding; UEX ORDINARY SHARES (UEXCF) Shorts Up By 32.73%

February 24, 2018 - By Peter Erickson

Oak Associates Ltd decreased Quest Diagnostics Inc (DGX) stake by 13.83% reported in 2017Q3 SEC filing. Oak Associates Ltd sold 4,300 shares as Quest Diagnostics Inc (DGX)’s stock rose 10.72%. The Oak Associates Ltd holds 26,800 shares with $2.51M value, down from 31,100 last quarter. Quest Diagnostics Inc now has $13.98 billion valuation. The stock increased 1.74% or $1.75 during the last trading session, reaching $102.6. About 766,595 shares traded. Quest Diagnostics Incorporated (NYSE:DGX) has risen 39.04% since February 24, 2017 and is uptrending. It has outperformed by 22.34% the S&P500.

UEX CORP ORDINARY SHARES (OTCMKTS:UEXCF) had an increase of 32.73% in short interest. UEXCF’s SI was 332,500 shares in February as released by FINRA. Its up 32.73% from 250,500 shares previously. With 121,300 avg volume, 3 days are for UEX CORP ORDINARY SHARES (OTCMKTS:UEXCF)’s short sellers to cover UEXCF’s short positions. The SI to UEX CORP ORDINARY SHARES’s float is 0.13%. The stock increased 6.48% or $0.0136 during the last trading session, reaching $0.2236. About 6,053 shares traded. UEX Corporation (OTCMKTS:UEXCF) has 0.00% since February 24, 2017 and is . It has underperformed by 16.70% the S&P500.

UEX Corporation engages in the exploration, development, and evaluation of uranium properties in Canada. The company has market cap of $71.78 million. The Company’s flagship project is the Shea Creek project located in northwest Saskatchewan. It currently has negative earnings.

Investors sentiment decreased to 0.98 in 2017 Q3. Its down 0.01, from 0.99 in 2017Q2. It fall, as 51 investors sold DGX shares while 184 reduced holdings. 57 funds opened positions while 173 raised stakes. 116.90 million shares or 2.64% more from 113.89 million shares in 2017Q2 were reported. Great West Life Assurance Com Can reported 262,706 shares. Wade G W And invested in 4,684 shares. Toronto Dominion State Bank stated it has 0.02% of its portfolio in Quest Diagnostics Incorporated (NYSE:DGX). Bancorp Of Montreal Can holds 0.02% or 254,160 shares in its portfolio. Price T Rowe Associates Md, a Maryland-based fund reported 248,462 shares. Bowling Portfolio Mngmt Limited Co invested in 0.42% or 30,143 shares. Peak6 Invs Lp has 0% invested in Quest Diagnostics Incorporated (NYSE:DGX) for 9 shares. New York-based Morgan Stanley has invested 0.04% in Quest Diagnostics Incorporated (NYSE:DGX). Moreover, Ferguson Wellman Cap Mgmt Inc has 0.01% invested in Quest Diagnostics Incorporated (NYSE:DGX). 1,276 were reported by Finance Architects. Strs Ohio owns 0.01% invested in Quest Diagnostics Incorporated (NYSE:DGX) for 18,953 shares. Janney Montgomery Scott Ltd Limited Liability Company reported 7,649 shares or 0.01% of all its holdings. Utah Retirement Systems holds 0.05% or 25,134 shares in its portfolio. Exane Derivatives reported 2 shares. State Street Corp invested 0.05% of its portfolio in Quest Diagnostics Incorporated (NYSE:DGX).

Analysts await Quest Diagnostics Incorporated (NYSE:DGX) to report earnings on April, 19. They expect $1.52 earnings per share, up 14.29% or $0.19 from last year’s $1.33 per share. DGX’s profit will be $207.17M for 16.88 P/E if the $1.52 EPS becomes a reality. After $1.38 actual earnings per share reported by Quest Diagnostics Incorporated for the previous quarter, Wall Street now forecasts 10.14% EPS growth.

Since September 5, 2017, it had 0 insider buys, and 7 sales for $31.46 million activity. $6.41M worth of Quest Diagnostics Incorporated (NYSE:DGX) was sold by RUSCKOWSKI STEPHEN H on Monday, September 11. Doherty Catherine T. sold $2.21M worth of Quest Diagnostics Incorporated (NYSE:DGX) on Wednesday, January 24. 40,900 Quest Diagnostics Incorporated (NYSE:DGX) shares with value of $4.42 million were sold by STANZIONE DANIEL. The insider Davis J. E. sold 63,880 shares worth $6.30M.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>